Physician profile
Dawn Moon
NPI 1578921334
$1,194.74
in general payments reported to CMS, 2019-2025
10 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $341 · 2023: $176 · 2024: $322 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $326.72 | 2022-2025 | |
| Lilly USA, LLC | $206.54 | 2021-2023 | Mounjaro, Trulicity |
| Aimmune Therapeutics, INC. | $171.19 | 2024-2025 | Zenpep |
| Astrazeneca Pharmaceuticals LP | $136.71 | 2024-2025 | Lokelma |
| Neurocrine Biosciences, INC. | $124.88 | 2021 | |
| Janssen Pharmaceuticals, INC | $117.65 | 2022 | |
| Exact Sciences Corporation | $56.17 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $29.74 | 2024 | |
| Lucid Diagnostics INC. | $12.80 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.